Latest Press Releases
More Press Releases
HighPeak Energy, Inc. to Present at the Water Tower Research Insights Conference on April 15, 2026
FORT WORTH, Texas, April 13, 2026 (GLOBE NEWSWIRE) — HighPeak Energy, Inc. (NASDAQ: HPK) (“HighPeak Energy”), today
Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock
SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO) today
Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, a late-stage clinical oncology company
Correction: Oxford Lane Capital Corp. Announces Redemption of 2,800,000 Shares of 6.25% Series 2027 Term Preferred Stock
GREENWICH, Conn., April 13, 2026 (GLOBE NEWSWIRE) — This press release corrects a prior version published on April 1,
Investcorp AI Acquisition Corp. to Combine with Blue Finance Technology Holding Limited; Transaction to Create Irish Public Company Focused on Artificial Intelligence-Powered Digital Consumer Finance
Proposed business combination structured to result in a new Irish public company listed on the Nasdaq Capital Market
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) — BridgeBio Oncology Therapeutics, Inc., or BBOT
Navitas Semiconductor Appoints Gregory M. Fischer as Independent Director to its Board
Ex-Broadcom Executive Brings Over 40 Years of Semiconductor Technology and Business Leadership Experience to Navitas’
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to
Dorman Products, Inc. Announces Date to Report First Quarter 2026 Financial Results
COLMAR, Pa., April 13, 2026 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM) today
INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, April 13, 2026 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that